monobromobimane has been researched along with alprostadil in 1 studies
| Studies (monobromobimane) | Trials (monobromobimane) | Recent Studies (post-2010) (monobromobimane) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
|---|---|---|---|---|---|
| 199 | 1 | 42 | 7,136 | 864 | 761 |
| Protein | Taxonomy | monobromobimane (IC50) | alprostadil (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mauss, EA; Milot, DC; Puszkin, EG; Zucker, MB | 1 |
1 other study(ies) available for monobromobimane and alprostadil
| Article | Year |
|---|---|
Effect of the thiol group inhibitor monobromobimane and other inhibitors on the composition of the platelet cytoskeletal core and its association with glycoprotein IIIa.
Topics: Alprostadil; Blood Platelets; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Concanavalin A; Cytoskeleton; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Sulfhydryl Reagents; Thrombin | 1989 |